Eyenovia Announces Confirmatory Results from Second MicroStat Phase III Registration Study for Mydriasis
Eyenovia Announces FDA Acceptance of IND Application for MicroPine to Reduce the Progression of Myopia
Eyenovia Completes Patient Enrollment in MicroStat MIST-1 Study and Enrolls First Patient in MIST-2 Study
Element79 Gold Corp Announces Corporate Update and Strategic Leadership Changes With Focus On Accelerating Nevada Asset Development
